The influence of supplemental docosahexaenoic and arachidonic acids during pregnancy and lactation on neurodevelopment at eighteen months

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 84, Issue 5-6, 2011, Pages 139-146

  Van Goor, Saskia A ^a   Janneke Dijck Brouwer, D A ^a   Erwich, Jan Jaap H M ^a   Schaafsma, Anne ^b   Hadders Algra, Mijna ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b FRIESLANDCAMPINA   (Netherlands)

Author keywords

Arachidonic acid; Association; Bayley Scales of Infant Development; BSID; Docosahexaenoic acid; Fish oil; Hempel; Intervention; Mead acid; Toddler

Indexed keywords

5,8,11 ICOSATRIENOIC ACID; ARACHIDONIC ACID; DOCOSAHEXAENOIC ACID; OMEGA 6 FATTY ACID;

ADULT; ARTICLE; BRAIN DEVELOPMENT; CHILD; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; INFANT; LACTATION; LIPID COMPOSITION; MENTAL DEVELOPMENT; NERVOUS SYSTEM DEVELOPMENT; NEUROLOGIC EXAMINATION; OUTCOME ASSESSMENT; PREGNANCY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ARACHIDONIC ACID; CHILD; DIETARY SUPPLEMENTS; DOCOSAHEXAENOIC ACIDS; FEMALE; HUMANS; INFANT; LACTATION; MOTOR ACTIVITY; NERVOUS SYSTEM DISEASES; PREGNANCY; PRENATAL NUTRITIONAL PHYSIOLOGICAL PHENOMENA; UMBILICAL CORD;

EID: 79953280772     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.plefa.2011.01.002     Document Type: Article

References (45)

1. Innis S.M. Fatty acids and early human development. Early Hum. Dev. 2007, 83:761-766.
2. Serhan C.N., Chiang N. Endogenous pro-resolving and anti-inflammatory lipid mediators: a new pharmacologic genus. Br. J. Pharmacol. 2008, 153(Suppl. 1):S200-S215.
3. Martinez M. Tissue levels of polyunsaturated fatty acids during early human development. J. Pediatr. 1992, 120:S129-S138.
4. McCann J.C., Ames B.N. Is docosahexaenoic acid, an n-3 long-chain polyunsaturated fatty acid, required for development of normal brain function? an overview of evidence from cognitive and behavioral tests in humans and animals. Am. J. Clin. Nutr. 2005, 82:281-295.
5. Judge M.P., Harel O., Lammi-Keefe C.J. A docosahexaenoic acid-functional food during pregnancy benefits infant visual acuity at four but not six months of age. Lipids 2007, 42:117-122.
6. Hadders-Algra M. Prenatal long-chain polyunsaturated fatty acid status: the importance of a balanced intake of docosahexaenoic acid and arachidonic acid. J. Perinat. Med. 2008, 36:101-109.
7. Bouwstra H., Dijck-Brouwer D.A., Boehm G., Boersma E.R., Muskiet F.A., Hadders-Algra M. Long-chain polyunsaturated fatty acids and neurological developmental outcome at 18 months in healthy term infants. Acta Paediatr. 2005, 94:26-32.
8. M.S. Hempel, The neurological examination for toddler age (1993).
9. Huisman M., Koopman-Esseboom C., Lanting C.I., et al. Neurological condition in 18-month-old children perinatally exposed to polychlorinated biphenyls and dioxins. Early Hum. Dev. 1995, 43:165-176.
10. Bouwstra H., Dijck-Brouwer D.A., Decsi T., et al. Neurologic condition of healthy term infants at 18 months: positive association with venous umbilical DHA status and negative association with umbilical trans-fatty acids. Pediatr. Res. 2006, 60:334-339.
11. Lanting C.I., Patandin S., Weisglas-Kuperus N., Touwen B.C., Boersma E.R. Breastfeeding and neurological outcome at 42 months. Acta Paediatr. 1998, 87:1224-1229.
12. Bouwstra H., Dijck-Brouwer D.A., Decsi T., et al. Relationship between umbilical cord essential fatty acid content and the quality of general movements of healthy term infants at 3 months. Pediatr. Res. 2006, 59:717-722.
13. van Goor S.A., Di jck-Brouwer D.A., Doornbos B., et al. Supplementation of DHA but not DHA with arachidonic acid during pregnancy and lactation influences general movement quality in 12-week-old term infants. Br. J. Nutr. 2010, 103:235-242.
14. Hadders-Algra M. Putative neural substrate of normal and abnormal general movements. Neurosci. Biobehav. Rev. 2007, 31:1181-1190.
15. Doornbos B., van Goor S.A., Dijck-Brouwer D.A., Schaafsma A., Korf J., Muskiet F.A. Supplementation of a low dose of DHA or DHA+AA does not prevent peripartum depressive symptoms in a small population based sample. Prog. Neuropsychopharmacol. Biol. Psychiatry 2009, 33:49-52.
16. van Goor S.A., Dijck-Brouwer D.A., Hadders-Algra M., et al. Human milk arachidonic acid and docosahexaenoic acid contents increase following supplementation during pregnancy and lactation. Prostaglandins Leukot. Essent. Fatty Acids 2009, 80:65-69.
17. Touwen B.C., Huisjes H.J., Jurgens-van der Zee A.D., Bierman-van Eendenburg M.E.C., Smrkovsky, Olinga A.A. Obstetrical condition and neonatal neurological morbidity. an analysis with the help of the optimality concept. Early Hum. Dev. 1980, 4:207-228.
18. Astorg P., Arnault N., Czernichow S., Noisette N., Galan P., Hercberg S. Dietary intakes and food sources of n-6 and n-3 PUFA in french adult men and women. Lipids 2004, 39:527-535.
19. B.F. van der Meulen, S.A.J. Ruiter, H.C. Lutje Spelberg, M. Smrkovsky, Bayley Scales of Infant Development-II Nancy Bayley-Dutch Version-Handbook, 2002.
20. Hadders-Algra M. Developmental coordination disorder: is clumsy motor behavior caused by a lesion of the brain at early age?. Neural Plast. 2003, 10:39-50.
21. Muskiet F.A., van Doormaal J.J., Martini I.A., Wolthers B.G., van der Slik W. Capillary gas chromatographic profiling of total long-chain fatty acids and cholesterol in biological materials. J.Chromatogr. 1983, 278:231-244.
22. Volmer M., Meiborg G., Muskiet F.A. Simultaneous capillary gas chromatographic profiling of medium- and long-chain fatty acid methyl esters with split injection. correction for injection-related discrimination by the 'bracketing' method. J. Chromatogr. 1988, 434:385-394.
23. Hadders-Algra M., Bouwstra H., van Goor S.A., Dijck-Brouwer D.A., Muskiet F.A. Prenatal and early postnatal fatty acid status and neurodevelopmental outcome. J. Perinat. Med. 2007, 35(Suppl. 1):S28-S34.
24. Makrides M., Gibson R.A., McPhee A.J., et al. Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: a randomized controlled trial. J. Am. Med. Assoc. 2010, 304:1675-1683.
25. Innis S.M., Friesen R.W. Essential n-3 fatty acids in pregnant women and early visual acuity maturation in term infants. Am. J. Clin. Nutr. 2008, 87:548-557.
26. van Goor S.A., Schaafsma A., Erwich J.J., Di jck-Brouwer D.A., Muskiet F.A. Mildly abnormal general movement quality in infants is associated with higher mead acid and lower arachidonic acid and shows a U-shaped relation with the DHA/AA ratio. Prostaglandins Leukot. Essent. Fatty Acids 2009.
27. M. Hadders-Algra, Prenatal and early postnatal supplementation with long-chain polyunsaturated fatty acids-neurodevelopmental considerations, Am. J. Clin. Nutr., in press.
28. Bouwstra H., Dijck-Brouwer D.A., Wildeman J.A., et al. Long-chain polyunsaturated fatty acids have a positive effect on the quality of general movements of healthy term infants. Am. J. Clin. Nutr. 2003, 78:313-318.
29. de Jong C., Kikkert H.K., Fidler V., Hadders-Algra M. The groningen LCPUFA study: no effect of postnatal long-chain polyunsaturated fatty acids in healthy term infants on neurological condition at 9 years. Br. J. Nutr. 2010, 104:566-572.
30. McNamara R.K., Carlson S.E. Role of omega-3 fatty acids in brain development and function: potential implications for the pathogenesis and prevention of psychopathology. Prostaglandins Leukot. Essent. Fatty Acids 2006, 75:329-349.
31. Chalon S., Vancassel S., Zimmer L., Guilloteau D., Durand G. Polyunsaturated fatty acids and cerebral function: focus on monoaminergic neurotransmission. Lipids 2001, 36:937-944.
32. Levant B., Radel J.D., Carlson S.E. Decreased brain docosahexaenoic acid during development alters dopamine-related behaviors in adult rats that are differentially affected by dietary remediation. Behav. Brain Res. 2004, 152:49-57.
33. Levant B., Ozias M.K., Carlson S.E. Sex-specific effects of brain LC-PUFA composition on locomotor activity in rats. Physiol. Behav. 2006, 89:196-204.
34. Jacobson J.L., Jacobson S.W., Muckle G., Kaplan-Estrin M., Ayotte P., Dewailly E. Beneficial effects of a polyunsaturated fatty acid on infant development: evidence from the inuit of arctic quebec. J. Pediatr. 2008, 152:356-364.
35. Dirix C.E., Hornstra G., Nijhuis J.G. Fetal learning and memory: weak associations with the early essential polyunsaturated fatty acid status. Prostaglandins Leukot. Essent. Fatty Acids 2009, 80:207-212.
36. Helland I.B., Smith L., Saarem K., Saugstad O.D., Drevon C.A. Maternal supplementation with very-long-chain n-3 fatty acids during pregnancy and lactation augments children's IQ at 4 years of age. Pediatrics 2003, 111:e39-e44.
37. Muskiet F.A., van Goor S.A., Kuipers R.S., et al. Long-chain polyunsaturated fatty acids in maternal and infant nutrition. Prostaglandins Leukot. Essent. Fatty Acids 2006, 75:135-144.
38. Hanebutt F.L., Demmelmair H., Schiessl B., Larque E., Koletzko B. Long-chain polyunsaturated fatty acid (LC-PUFA) transfer across the placenta. Clin. Nutr. 2008, 27:685-693.
39. K.F.A.M. Hulshof, M.C. Ocke, C.T.M. van Rossum, et al., Results of the national food consumption survey 2003, RIVM report 350030002/2004, 2004.
40. Simmer K., Patole S.K., Rao S.C. Longchain polyunsaturated fatty acid supplementation in infants born at term. Cochrane Database Syst. Rev. 2008, CD000376.
41. Dunstan J.A., Simmer K., Dixon G., Prescott S.L. Cognitive assessment of children at age 2(1/2) years after maternal fish oil supplementation in pregnancy: a randomised controlled trial. Arch. Dis. Child. Fetal Neonatal Ed. 2008, 93:F45-F50.
42. Williams C., Birch E.E., Emmett P.M., Northstone K. Stereoacuity at age 3.5 y in children born full-term is associated with prenatal and postnatal dietary factors: a report from a population-based cohort study. Am. J. Clin. Nutr. 2001, 73:316-322.
43. Ghys A., Bakker E., Hornstra G., van den Hout M. Red blood cell and plasma phospholipid arachidonic and docosahexaenoic acid levels at birth and cognitive development at 4 years of age. Early Hum. Dev. 2002, 69:83-90.
44. Colombo J., Kannass K.N., Shaddy D.J., et al. Maternal DHA and the development of attention in infancy and toddlerhood. Child Dev. 2004, 75:1254-1267.
45. Hibbeln J.R., Davis J.M., Steer C., et al. Maternal seafood consumption in pregnancy and neurodevelopmental outcomes in childhood (ALSPAC study): an observational cohort study. Lancet 2007, 369:578-585.